Enzymotec Company Profile (NASDAQ:ENZY)

Analyst Ratings

Consensus Ratings for Enzymotec (NASDAQ:ENZY) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $9.50 (5.44% upside)

Analysts' Ratings History for Enzymotec (NASDAQ:ENZY)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2016Jefferies GroupReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Enzymotec (NASDAQ:ENZY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/10/2016        
5/19/2016Q116$0.05$0.09$13.85 million$14.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$0.10$0.07$14.01 million$13.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2015Q315$0.07$0.08$14.21 million$12.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215$0.06$0.11$12.39 million$13.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.06$0.09$12.10 million$12.25 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2015Q414$0.08$0.06$11.11 million$10.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014Q314$0.04$0.05$10.22 million$9.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.10$0.02$14.88 million$11.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/14/2014Q114$0.17$0.24$19.40 million$23.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2014Q413$0.11$0.15$11.64 million$18.51 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2013Q313$0.11$0.13$13.10 million$22.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Enzymotec (NASDAQ:ENZY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.05$0.05$0.05
Q2 20161$0.08$0.08$0.08
Q3 20161$0.06$0.06$0.06
Q4 20161$0.07$0.07$0.07
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Enzymotec (NASDAQ:ENZY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Enzymotec (NASDAQ:ENZY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Enzymotec (NASDAQ:ENZY)
DateHeadline
07/26/16 07:38 AMEnzymotec to Report Second Quarter 2016 Financial Results - [at noodls] - July 26, 2016 MIGDAL HA'EMEQ, Israel, July 26, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients ...
07/18/16 02:38 AM2016-07-18 Enzymatica AB: Excellent volume growth for ColdZyme® - [at noodls] - Enzymatica AB: Excellent volume growth for ColdZyme® 2016-07-18 Q2 Net sales reached SEK 4.9 (3.1) million. Loss after tax came in at SEK -12.3 (-10.4) thousand. Earnings per share were SEK -0.20 (-0.42). ...
07/15/16 02:51 PMEnzymotec Ltd. Calls for its 2016 Annual General Meeting of Shareholders
07/13/16 04:18 PMCORRECTING and REPLACING -- Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders - [at noodls] - July 13, 2016 In the news release, Enzymotec Ltd. Calls its 2016 Annual General Meeting of Shareholders, issued July 13, 2016 by Enzymotec Ltd., we are advised by the company of the following amendments ...
07/03/16 08:25 AMJulian Robertson Sells Half of Stake in John Paulson-Backed Company
07/01/16 06:16 PMJulian Robertson Cuts Half of Stake in Paulson-Backed Company -
07/01/16 11:38 AMEnzymotec (ENZY): Julian Robertson’s Tiger Management Dumps Half of Its Stake -
06/14/16 03:45 PMBaby Nutrition Market Insights Analyse of Current and Forecast Industry Position in 2016 Report- Issue 27
06/06/16 03:45 PMGlobal Global Krill Oil Market to Reach US $703.0 Mn by 2022 : PMR
06/06/16 03:45 PMPhytosterols Market Size Estimated to Reach $989.8 Million by 2020: Grand View Research, Inc.
06/02/16 04:01 PMKrill Oil Market will hit US$ 703.0 Mn by 2022, Globally : PMR Report - Key players in the global krill oil market include Qingdao Kangjing Marine Biotechnology Co., Ltd., Enzymotec Ltd., RB LLC., NWC Naturals Inc., NutriGold Inc., Daeduck FRD Inc., Aker BioMarine SA, Neptune Technologies & Bioressources Inc., and Olympic ...
05/28/16 06:56 PMEnzymotec Limited Ord (NASDAQ:ENZY) Shorted Shares Decreased By 32.77% - HNN - Enzymotec Limited Ord (NASDAQ:ENZY) Shorted Shares Decreased By 32.77%HNNThe stock of Enzymotec Limited Ord (NASDAQ:ENZY) registered a decrease of 32.77% in short interest. ENZY's total short interest was 35,900 shares in May as published by FINRA. Its down 32.77% from 53,400 shares, reported previously. With 51,500 ...and more »
05/27/16 07:23 PMEarnings Review and Stock Rundown for Enzymotec Ltd. (NASDAQ:ENZY) - Wall Street Hints and News - Earnings Review and Stock Rundown for Enzymotec Ltd. (NASDAQ:ENZY)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Enzymotec Ltd. (NASDAQ:ENZY) to post ...and more »
05/26/16 07:13 PMRevenue Update on Enzymotec Ltd(NASDAQ:ENZY) - Trade Calls - Revenue Update on Enzymotec Ltd(NASDAQ:ENZY)Trade CallsEnzymotec Ltd(NASDAQ:ENZY) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 19, 2016. Company reported revenue of $13.97M. Analysts estimated a revenue of $13.85M. Earnings per share ...
05/25/16 07:46 AM2016-05-25 Bulletin from the Annual General Meeting in Enzymatica AB (publ) - [at noodls] - Bulletin from the Annual General Meeting in Enzymatica AB (publ) 2016-05-25 Press release Lund on 25 May 2016 Today on 25 May 2016, the Annual General Meeting was held in Enzymatica AB (publ). A summary ...
05/23/16 12:55 PMEnzymotec Ltd. :ENZY-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 -
05/22/16 06:26 PMAfter Last Week What Do Analysts Think Of Enzymotec Ltd. (NASDAQ:ENZY) - Share Trading News - After Last Week What Do Analysts Think Of Enzymotec Ltd. (NASDAQ:ENZY)Share Trading NewsThe share price of Enzymotec Ltd. (NASDAQ:ENZY) was down -0.61% during the last trading session, with a day high of 8.41. 57252 shares were traded on Enzymotec Ltd.'s last session. The stock's 50 day moving average is 8.40 and its 200 day moving ...Trader's Recap: Alliqua Biomedical Inc (NASDAQ:ALQA), Autodesk, Inc. (NASDAQ:ADSK), Dick's Sporting Goods Inc ...Benchmark Monitorall 3 news articles »
05/22/16 11:44 AMHow Many Enzymotec Ltd (NASDAQ:ENZY)'s Analysts Are Bearish? - Wall Street Hints and News - How Many Enzymotec Ltd (NASDAQ:ENZY)'s Analysts Are Bearish?Wall Street Hints and NewsOut of 2 analysts covering Enzymotec (NASDAQ:ENZY), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. Enzymotec has been the topic of 4 analyst reports since August 13, 2015 according to StockzIntelligence Inc. Below is a list ...
05/21/16 12:05 AMEnzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results - GlobeNewswire (press release) - Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial ResultsGlobeNewswire (press release)MIGDAL HA'EMEQ, Israel, May 19, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today reported financial results for the first quarter ended ...Enzymotec Ltd (ENZY) Releases Earnings Results, Beats Expectations By $0.04 EPSMarket DigestEnzymotec Ltd. (NASDAQ:ENZY) To Report EarningsRisers & FallersEnzymotec Limited Ord (NASDAQ:ENZY) Shorts Decreased by 2.73% After Short CoveringWall Street Hints and NewsSonoran Weekly Reviewall 7 news articles »
05/20/16 06:58 PMLatest Analyst Ratings For Enzymotec Ltd. (NASDAQ:ENZY) - Share Trading News - Latest Analyst Ratings For Enzymotec Ltd. (NASDAQ:ENZY)Share Trading News02/18/2016 – Enzymotec Ltd. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 10 price target on the stock. 08/13/2015 – Enzymotec Ltd. was upgraded to “outperform” by analysts at Wells Fargo. 05/15/2015 – Enzymotec ...and more »
05/20/16 10:33 AMEdited Transcript of ENZY earnings conference call or presentation 19-May-16 12:30pm GMT -
05/20/16 12:12 AMEnzymotec Ltd.: Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results - The Wall Street Transcript - Enzymotec Ltd.: Enzymotec Ltd. Reports First Quarter 2016 Unaudited Financial ResultsThe Wall Street TranscriptMIGDAL HA'EMEQ, Israel, May 19, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and medical foods, today reported financial results for the first quarter ended ...Enzymotec Ltd. (NASDAQ:ENZY) To Report EarningsRisers & FallersEnzymotec Ltd (ENZY) Releases Earnings Results, Beats Expectations By $0.04 EPSMarket DigestEnzymotec Limited Ord (NASDAQ:ENZY) Shorts Decreased by 2.73% After Short CoveringWall Street Hints and NewsSonoran Weekly Reviewall 7 news articles »
05/19/16 06:59 PMBRIEF-Enzymotec Ltd Q1 non-gaap earnings per share $0.09 - Reuters - BRIEF-Enzymotec Ltd Q1 non-gaap earnings per share $0.09ReutersMay 19 Enzymotec Ltd. * Company reaffirms its previously issued guidance for 2016. * Q1 net revenues increased 23.6% and 5.3% to $14.0 million, compared to q1 of 2015 and q4 of 2015, respectively. * Fy2016 earnings per share view $0.27, revenue view ...
05/19/16 06:59 PMKrill Oil Market Has Been Estimated to Be Valued at US$ 300.7 Mn by the End of 2015, Globally - Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/6721 Key players in the global krill oil market include Qingdao Kangjing Marine Biotechnology Co., Ltd., Enzymotec Ltd., RB LLC., NWC Naturals Inc., NutriGold Inc., Daeduck ...
05/19/16 06:59 PMBRIEF-Enzymotec Ltd Q1 non-gaap earnings per share $0.09 - * Q1 net revenues increased 23.6% and 5.3% to $14.0 million, compared to q1 of 2015 and q4 of 2015, respectively * Fy2016 earnings per share view $0.27, revenue view $60.1 million -- Thomson Reuters I/B/E/S * Enzymotec ltd. Reports first quarter 2016 ...
05/19/16 07:32 AMEnzymotec Ltd. Reports First Quarter 2016 Unaudited Financial Results - [at noodls] - May 19, 2016 Reports Net Revenues of $14.0 Million, Earns $0.09 Per Diluted Share (non-GAAP) and Generates $3.3 Million in Operating Cash Flow VAYA Pharma Generates Record Net Revenues of $3.1 Million ...
05/19/16 06:55 AMEnzymotec beats 1Q profit forecasts -
05/19/16 06:42 AM7:42 am Enzymotec beats by $0.04, reports revs in-line; reaffirms FY16 EPS guidance, revs guidance -
05/19/16 06:07 AMQ1 2016 Enzymotec Ltd Earnings Release - Before Market Open -
05/17/16 06:44 PMAlpha One Assigns Impact Score Of 100 To Enzymotec Ltd. (NASDAQ:ENZY) - Investor Newswire - Alpha One Assigns Impact Score Of 100 To Enzymotec Ltd. (NASDAQ:ENZY)Investor NewswireAlpha One analyzed the various web articles published on Enzymotec Ltd. (NASDAQ:ENZY), and thereafter it gave company a daily sentiment score of 0.31. The entity designs algorithm based assessment to known stock sentiment on stock after considering ...and more »
05/16/16 12:23 PMEnzymotec Ltd : quaterly earnings release - 03/29 Enzymotec Ltd. Granted Patents in U.S. for Compositions and Processes Related.. 03/16 InCog™, Enzymotec's Innovative Lipid Composition for Cognitive Function.. 03/08 Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 20.
05/11/16 07:43 PMPerformance Recap and Target Perspective on Enzymotec Ltd. (NASDAQ:ENZY) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Enzymotec Ltd. (NASDAQ:ENZY)B.O.D.Y ConfidentialIn the latest trading session, shares of Enzymotec Ltd. (NASDAQ:ENZY) moved -0.73%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/11/16 05:42 AM2016-05-11 Enzymatica's new rights issue completed - will be provided with SEK 60 million - [at noodls] - Enzymatica's new rights issue completed - will be provided with SEK 60 million 2016-05-11 This press release may not be published or distributed, directly or indirectly, in or into the United States, Australia, ...
05/10/16 07:28 PMEnzymotec Ltd. (NASDAQ:ENZY) Latest Impact Score At 100 - Investor Newswire - Enzymotec Ltd. (NASDAQ:ENZY) Latest Impact Score At 100Investor NewswireEnzymotec Ltd. (NASDAQ:ENZY) has a 0.31 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published on different ...and more »
05/08/16 09:00 PMNext Weeks Broker Price Targets For Enzymotec Ltd. (NASDAQ:ENZY) - Share Trading News - Next Weeks Broker Price Targets For Enzymotec Ltd. (NASDAQ:ENZY)Share Trading News02/18/2016 – Enzymotec Ltd. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 10 price target on the stock. 08/13/2015 – Enzymotec Ltd. was upgraded to “outperform” by analysts at Wells Fargo. 05/15/2015 – Enzymotec ...and more »
05/07/16 12:35 AMEarnings Outlook on Enzymotec Ltd. (NASDAQ:ENZY) - B.O.D.Y Confidential - Earnings Outlook on Enzymotec Ltd. (NASDAQ:ENZY)B.O.D.Y ConfidentialAnalysts and investors will be anticipating Enzymotec Ltd. (NASDAQ:ENZY)'s next earnings release which is expected to be posted on or around 2016-05-19. Sell-side research firms on Wall Street are expecting that the company will post EPS of $0.05 for ...and more »
05/05/16 08:18 PMAverage Analyst Rating for Enzymotec Ltd. (NASDAQ:ENZY) - B.O.D.Y Confidential - Average Analyst Rating for Enzymotec Ltd. (NASDAQ:ENZY)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 2.67 on Enzymotec Ltd. (NASDAQ:ENZY) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/05/16 07:51 AMEnzymotec to Report First Quarter 2016 Financial Results - [at noodls] - May 5, 2016 MIGDAL HA'EMEQ, Israel, May 05, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and ...
05/04/16 07:19 PMGlobal Krill Oil Market Is Expected to Be Valued at US$ 703.0 Mn by 2022 : PMR - View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/krill-oil-market.asp Key players in the global krill oil market include Qingdao Kangjing Marine Biotechnology Co., Ltd., Enzymotec Ltd., RB LLC., NWC Naturals Inc ...
05/04/16 08:00 AMNew Survey Shows Nearly 3 Out of 4 Children Treated for ADHD Have Taken a “Drug Holiday” - [GlobeNewswire] - National VAYA™ Pharma Survey Reveals Drug Holidays are Mostly Prompted by Physicians and the Desire to Reduce Medication Side Effects. BALTIMORE, May 04, 2016-- Approximately 6.4 million children in the ...
05/03/16 03:20 AM2016-05-03 Enzymatica insiders plan to subscribe for SEK 16 million in new issue - [at noodls] - Enzymatica insiders plan to subscribe for SEK 16 million in new issue 2016-05-03 Enzymatica announces that insiders such as board members, senior executives and their family members plan to subscribe for ...
05/02/16 08:54 PMEnzymotec Ltd. (NASDAQ:ENZY) Broker Price Targets For The Coming Week - Share Trading News - Enzymotec Ltd. (NASDAQ:ENZY) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Enzymotec Ltd. (NASDAQ:ENZY). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/27/16 08:08 PMShare Performance and Target Price Review Enzymotec Ltd. (NASDAQ:ENZY) - B.O.D.Y Confidential - Share Performance and Target Price Review Enzymotec Ltd. (NASDAQ:ENZY)B.O.D.Y ConfidentialDuring the most recent trading session, shares of Enzymotec Ltd. (NASDAQ:ENZY) ended up with a move of -0.24%. Sell-side analysts have given a consensus target price of $8.50 on company shares. Target price projections may differ greatly from one ...and more »
04/27/16 08:08 PMRecently Changed Price Targets On Enzymotec Ltd. (NASDAQ:ENZY) - Risers & Fallers - Recently Changed Price Targets On Enzymotec Ltd. (NASDAQ:ENZY)Risers & Fallers05/15/2015 – Enzymotec Ltd. was upgraded to “strong-buy” by analysts at Zacks. They now have a USD 10 price target on the stock. 05/15/2014 – Enzymotec Ltd. had its “outperform” rating reiterated by analysts at Wedbush. They now have a USD 25 price ...
04/26/16 07:20 PMAnalyst Coverage: Enzymotec Ltd. (NASDAQ:ENZY) - Risers & Fallers - Analyst Coverage: Enzymotec Ltd. (NASDAQ:ENZY)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Enzymotec Ltd. (NASDAQ:ENZY). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...Enzymotec Limited Ord (NASDAQ:ENZY) Short Interest Decreased By 10.15%B.O.D.Y Confidentialall 2 news articles »
04/26/16 07:20 PMEnzymotec Ltd. (NASDAQ:ENZY) Has An Impact Score Of 0 - Investor Newswire - Enzymotec Ltd. (NASDAQ:ENZY) Has An Impact Score Of 0Investor NewswireEnzymotec Ltd. (NASDAQ:ENZY) has been given a 0.439 daily sentiment score for the related articles published on web today. Alpha One offer algorithm-based analytics, which can help state stock sentiment based on the content published on different ...and more »
04/26/16 09:44 AM2016-04-26 Notice of annual general meeting in Enzymatica AB (publ) - [at noodls] - Notice of annual general meeting in Enzymatica AB (publ) 2016-04-26 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the ...
04/01/16 08:46 AM2016-04-01 Enzymatica completes acquisition of Zymetech and includes new board members and representative to the nomination committee - [at noodls] - Enzymatica completes acquisition of Zymetech and includes new board members and representative to the nomination committee 2016-04-01 Enzymatica AB (publ) ('Enzymatica') has today completed the acqusition ...
03/29/16 07:58 AMEnzymotec Ltd. Granted Patents in U.S. for Compositions and Processes Related to Infant Nutrition and China for INFAT® Uses Promoting Development of Beneficial Gut Flora and Reducing Infant Crying Duration - [at noodls] - March 29, 2016 MIGDAL HA'EMEQ, Israel, March 29, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients ...
03/24/16 02:41 AM2016-03-24 Acting CFO of Enzymatica appointed - [at noodls] - Acting CFO of Enzymatica appointed 2016-03-24 Bengt Jöndell has been appointed Acting CFO of Enzymatica with effect from 4 April. Johan Wennerholm, Enzymatica's current CFO, has decided to leave the company ...

Social

About Enzymotec

Enzymotec logoEnzymotec Ltd. is a nutritional ingredients and medical foods company. The Company's technologies, research expertise and clinical validation process enables it to develop solutions across a range of products. The Company operates in two segments: Nutrition segment and VAYA Pharma segment. Both of the Company's segments offer a range of products that leverage its lipid-related offerings. Its product suite addresses the entire human life-cycle, from infancy to old age, and comprises ingredients in products ranging from infant formula to nutritional supplements, as well as branded medical foods, sold only under a doctor's supervision. It markets its product portfolio to established global consumer companies and physicians and target large and growing consumer health and wellness markets. The Company's clinically-validated products include bio-functional lipid-based compounds designed to address dietary needs, medical disorders and common diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ENZY
  • CUSIP:
Key Metrics:
  • Previous Close: $9.01
  • 50 Day Moving Average: $8.45
  • 200 Day Moving Average: $8.48
  • P/E Ratio: 33.37
  • P/E Growth: 0.78
  • Market Cap: $204.27M
  • Beta: 1.16
  • Current Year EPS Consensus Estimate: $0.29 EPS
  • Next Year EPS Consensus Estimate: $0.62 EPS
Additional Links:
Enzymotec (NASDAQ:ENZY) Chart for Friday, July, 29, 2016